Erech Finance Cahalacha Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EFNC.TA research report →
Price Chart
About the company
Erech Finance Cahalacha Ltd, including its subsidiaries, provides diverse lending and credit solutions to small and medium-sized businesses, associations, and individual clients across Israel. The company's operations are structured into two main divisions: Non-Bank Credit and Biomed Drug. Additionally, Erech Finance Cahalacha Ltd is engaged in pharmaceutical research and development, concentrating on treatments for diabetes and cancer.
- CEO
- Yosef Yeshayahu Wasserman
- IPO
- 2010
- Employees
- 6
- HQ
- Jerusalem, IL
Get TickerSpark's AI analysis on EFNC.TA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.79M
- P/E
- -0.68
- PEG
- -0.01
- P/S
- 47.49
- P/B
- -0.58
- EV/EBITDA
- -3.04
- Div Yield
- 0.00%
- Gross Margin
- -1416.33%
- Op Margin
- -6888.78%
- Net Margin
- -6919.39%
- ROE
- 370.14%
- ROIC
- -85.15%
Latest fiscal year · YoY change
- Revenue
- $282.00K-97.4%
- Gross Profit
- $-1,859,000-128.5%
- Op Income
- $-17,872,000
- Net Income
- $-25,293,000-1.0%
- EPS
- $-9.97-1.0%
- OCF Growth
- +53.9%
- FCF Growth
- +54.0%
- 52W High
- $892.90
- 52W Low
- $267.50
- 50D MA
- $305.58
- 200D MA
- $433.85
- Beta
- 1.35
- RSI (14)
- 16
- Avg Volume
- 716
No earnings-call transcripts are available for EFNC.TA yet.
- Free Float
- 54.4%
- Shares Outstanding
- 2.54M
- Float Shares
- 1.38M
Our EFNC.TA coverage
Recent articles, reports, and earnings notes.
No research on EFNC.TA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EFNC.TA report →